Trial Profile
Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2020
Price :
$35
*
At a glance
- Drugs Rifapentine (Primary) ; Ethambutol; Isoniazid; Moxifloxacin; Pyrazinamide; Rifampicin
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- Acronyms TBTCS31
- 21 Apr 2016 New trial record